Skip to main content
. 2009 Jun 24;3(3):425–433. doi: 10.1007/s12072-009-9140-3

Fig. 1.

Fig. 1

Association of hepatitis B e antigen (HBeAg) seropositivity with an increased incidence and relative risk of developing hepatocellular carcinoma (HCC). HBsAg, hepatitis surface antigen. Adapted from Yang et al. [4] with permission